Global multiplex assay market
is estimated to grow at a higher CAGR during the forecast period owing to its
benefits over conventional assays. Multiplex assays are extensively used in
functional genomics to determine biomolecule state of a particular class within
a biological sample. The trial is carried out to detect the impact of
experiment on DNA mutation over all biomolecules.
Functionally, protein
immunoassays and enzyme immunoassays offer information about endogenous proteins
and also help in recognizing biomarker combination with a higher disease.
Currently, anti-body based platforms are fundamental for protein multiplex
arrays. Assay formats comprise suspension assays & planar assays that
utilize conventional immunometric principles.
View Full Report with TOC @ https://www.millioninsights.com/industry-reports/multiplex-assay-market
On a commercial scale,
multiplex assay is normally used in high-throughput screening settings in which
many specimens are analyzed using a multiplex assay. A multiple assay may not
be a high-throughput compulsorily, but a single multiplex assay produces data
for a large number of analytes. Therefore, with the growing popularity of
multiplex assays in research worldwide, the market of multiplex assay witnesses
a trajectory growth for the assessment period.
The key driving factors
responsible for the growth of multiplex assay industry includes adoption of
companion diagnostics for safety & efficacy of therapies. The rising need
for effective analytical platforms to minimize operational costs, benefits of
multiplexing over conventional form of assays propel the market growth during
the forecast period. Additionally, growing validation of biomarkers in protein
and molecular diagnostics are anticipated to drive the market growth.
Moreover, the need for
suitable and impactful platforms in research to minimize the operational costs
is fueling the market growth. However, heavy costs associated with the use of
multiplex assay instruments are likely to impede market growth for the forecast
period. Multiplex assay market is segmented into instruments, consumables, kits
and reagents, panels, accessories, software and services, based on products
& services. Consumables segment is anticipated to grow at a higher CAGR
during the forecast period due to rising demand for consumables.
Multiplex assay market is
segmented into planar nucleic acid assays, nucleic acid-based multiplex arrays,
bead-based nucleic acid assays, protein-based multiplex arrays, planar protein
assays, bead-based protein assays based on type. Protein based assays segment
is anticipated to rise at a higher CAGR during the forecast period owing to
inclination towards assays for research purpose.
Multiplex assay market is
segmented into multiplex polymerase chain reaction, multiplex arrays, planar
assays, bead-based assays, SIMOA technology, gold-nano particle technology,
antibody assays and cytometric bead-based assays. Multiplex assays are
estimated to rise at a higher CAGR since it offers several advantages over
traditional assays.
Multiplex assay market is
segmented into drug application, research & development, biomarker
discovery and validation, diseases & disorders, cancer, infectious
diseases, cardiac diseases, autoimmune diseases, alzheimer’s disease,
allergies, companion diagnostics, food & agriculture, forensic testing,
bone metabolism, fertility and toxicology studies, based on application.
Multiplex assay market is
segmented into hospitals, academic & research institutes, clinical
laboratories, pharmaceutical and biotechnology companies, blood banks, forensic
labs, nursing homes, local public health laboratories, based on end user.
Multiplex assay industry spans North America, Latin America, Europe,
Asia-Pacific, and Middle-East & Africa.
Request a Sample
Copy of This Report @ https://www.millioninsights.com/industry-reports/multiplex-assay-market/request-sample
Comments
Post a Comment